Latest Urinary Tract Infections (UTI) News
Investigators observe higher rates of clinical cure or microbiologic eradication in patients treated with plazomicin vs meropenem, including those with infections due to Enterobacteriaceae not susceptible to aminoglycosides.
Research team used novel algorithms to ID early symptoms of health declines in dementia patients.
For this study, the authors identified randomized controlled trials (RCTs) that compared SGLT2 inhibitors with placebo, no treatment, or another antidiabetic agent and reported on UTI outcome.
Poor clinical outcomes linked to extended spectrum cephalosporin-resistant Enterobacteriaceae.
A multiplex polymerase chain reaction assay detected bacteria species missed by traditional urine culture as well as more fastidious bacteria.
To investigate the risk of cardiovascular adverse effects associated with this antibiotic class, researchers conducted a systematic review, meta-analysis, and network meta-analysis using studies identified through a search of MEDLINE, EMBASE, and the Cochrane Library.
Results from phase 2 study in patients with multidrug-resistant Gram-negative uropathogens.
Depletion of Lactobacillus iners in the bladder appears to increase the risk of urinary tract infection following urogynecologic surgery, study finds.
During a 12-month study, women who drank 1.5 L of water daily in addition to their usual fluid intake reduced their mean number of cystitis episodes nearly by half.
Zemdri carries a Boxed Warning describing reports of nephrotoxicity, ototoxicity, and neuromuscular blockade, as well as fetal harm if administered during pregnancy.
Changes will describe hypoglycemic coma and clarify and identify mental health side effects.
Plazomicin, an aminoglycoside, was approved for treating complicated urinary tract infections in adults due to certain Enterobacteriaceae.
In a study of women with uncomplicated lower urinary tract infections, 70% of patients treated with nitrofurantoin had complete symptom resolution at 28 days vs 58% of those treated with fosfomycin.
Calculator reduces testing and decreases the number of urinary tract infections that were missed
Overall treatment success occurred in 98.4% of patients receiving meropenem-vaborbactam vs 94% for those receiving piperacillin-tazobactam.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)